Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Cancer. 2024 Mar 15;130(6):936-946. doi: 10.1002/cncr.35105. Epub 2023 Nov 14.
Cancer. 2024.
PMID: 37962093
Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
Dominici LS, Sineshaw HM, Jemal A, Lin CC, King TA, Freedman RA.
Dominici LS, et al.
Breast Cancer Res Treat. 2018 Jan;167(2):555-566. doi: 10.1007/s10549-017-4528-6. Epub 2017 Oct 9.
Breast Cancer Res Treat. 2018.
PMID: 28990127
Item in Clipboard
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer.
Balch SM, Vaz-Luis I, Li T, Tayob N, Jain E, Helvie K, Buendia-Buendia JE, Shannon E, Isakoff SJ, Tung NM, Krop IE, Lin NU, Wagle N, Freedman RA.
Balch SM, et al.
Breast Cancer Res Treat. 2021 Sep;189(2):411-423. doi: 10.1007/s10549-021-06329-x. Epub 2021 Jul 24.
Breast Cancer Res Treat. 2021.
PMID: 34302589
Clinical Trial.
Item in Clipboard
Cite
Cite